Information on the target
The target company, Jimin Health (603222.SH), is a healthcare enterprise that has recently ventured into the semiconductor industry by acquiring a significant stake in Changcheng Galaxy Technology Co., Ltd. Established in 2015, Changcheng Galaxy specializes in integrated circuit design, offering a range of products including DSP chips, SOCs for various industries, artificial intelligence chips, and microcontroller chips. The company has established a robust client base, serving over 1,500 upstream and downstream partners, including the top ten military industrial groups in China.
In its latest financial performance, Changcheng Galaxy reported an expected revenue of 3.67 billion yuan and a net profit of 1.26 billion yuan for the fiscal year 2025. However, the first quarter of 2026 showed a decline in net profit due to increased accounts receivable aging, leading to significant credit impairment losses. The company has set performance commitments for the next three years, ensuring a cumulative net profit of no less than 360 million yuan, with penalties for underperformance.
Industry overview in the target’s specific country
The integrated circuits industry in China has been experiencing rapid growth, driven by the country's push for technological self-sufficiency and advancements in various sectors, including telecommunications, consumer electronics, and automotive. The Chinese government has implemented policies to support domestic semiconductor production, aiming to reduce reliance on foreign technology and enhance national security. This has resulted in increased investments in research and development, as well as the establishment of numerous semiconductor manufacturing facilities across the country.
China's integrated circuits market is projected to expand significantly, with a compound annual growth rate (CAGR) that outpaces global averages. The demand for integrated circuits is being fueled by the rise of artificial intelligence, the Internet of Things (IoT), and 5G technology, which require advanced semiconductor solutions. However, the industry faces challenges, including high production costs, a shortage of skilled labor, and intense competition from established global players.
Moreover, the geopolitical landscape has further complicated the industry dynamics, as trade tensions and export restrictions have prompted Chinese companies to accelerate their efforts in developing indigenous technologies. This has led to a surge in mergers and acquisitions within the sector, as companies seek to bolster their capabilities and market positions. The integrated circuits industry in China is thus at a pivotal moment, balancing opportunities for growth with the need for strategic adaptation to external pressures.
The rationale behind the deal The acquisition of Changcheng Galaxy by Jimin Health represents a strategic pivot for the company, which has been facing challenges in its core healthcare business. By entering the semiconductor sector, Jimin Health aims…